Memorial Göztepe Hospital
Memorial Göztepe Hospital
Turcja, Stambuł
Państwo nie płacą za usługi Bookimed. Ceny leczenia anemii fanconiego odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w leczeniu anemii Fanconiego. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas leczenia anemii Fanconiego.
Prof. MD Zafer Gulbas jest specjalistą onkologii medycznej i hematologii, dyrektorem onkologii medycznej w Anadolu Medical Center i założycielem Bone Marrow Transplantation Center w Anadolu. Jest wysoko wykwalifikowanym hematologiem-onkologiem, specjalizującym się w przeszczepach szpiku kostnego, z wykształceniem z Hacettepe University Medical School, Anadolu University Medical School, Atatürk Pulmonary Diseases and Thoracic Surgery Center, Hadassah Medical Center, Fred Hutchinson Cancer Research Center, MDAnderson Cancer Research Center i Toronto University Princess Margaret Hospital.
Specialized Turkish hospitals like Anadolu Medical Center and Acibadem Altunizade offer advanced Fanconi Anemia care. These centers feature dedicated hematology-oncology departments and bone marrow transplant units. Many maintain Joint Commission International accreditation and specific European Blood and Marrow Transplantation certifications for complex marrow failure syndromes.
Bookimed Expert Insight: Success in Fanconi Anemia depends on experience with allogeneic transplants for inherited syndromes. Anadolu Medical Center reports an 81% success rate for autologous transplants specifically. This high volume often leads to better management of the unique conditioning regimens required. Dr. Zafer Gulbas leads these efforts, bringing expertise from top global institutions like M.D. Anderson.
Patient Consensus: Patients emphasize finding teams experienced in inherited marrow failure rather than general oncology. They note that coordinating with genetics and fertility counseling is vital for long-term care.
Turkish centers treat Fanconi Anemia through curative hematopoietic stem cell transplantation. Specialized units at Anadolu Medical Center utilize protocols from Johns Hopkins Medicine. Options include matched sibling and unrelated donor transplants. Centers provide androgen therapy and leukodepleted transfusions to manage bone marrow failure before surgery.
Bookimed Expert Insight: Anadolu Medical Center stands out because Dr. Zafer Gulbas has performed over 3,300 procedures. This high volume is critical for Fanconi Anemia cases. Such rare conditions require surgeons who manage thousands of transplants to ensure safety. The center's partnership with Johns Hopkins provides access to specialized reduced-intensity conditioning protocols.
Patient Consensus: Families emphasize finding centers with dedicated pediatric hematology programs for long-term monitoring. Patients note that starting leukodepleted transfusions early helps avoid complications during the eventual transplant process.
Turkish referral centers report overall survival rates for Fanconi anemia patients exceeding 70% to 80% following bone marrow transplantation. Success hinges on specialized reduced-intensity conditioning regimens. Leading facilities like ACIBADEM report survival rates near 85% by using advanced haploidentical and unrelated donor transplant techniques.
Bookimed Expert Insight: Success often depends on cumulative institutional experience rather than just technology. For example, Dr. Zafer Gulbas at Anadolu Medical Center has overseen 3,000+ transplants since 2010. This high volume allows centers to refine the delicate conditioning balance required for Fanconi anemia patients.
Turkish physicians are highly proficient in treating Fanconi Anemia through specialized hematology and bone marrow transplant centers. Experts like Dr. Zafer Gulbas have performed over 3,000 transplants since 2010. Turkish facilities often use Johns Hopkins Medicine International protocols for managing complex genetic blood disorders.
Bookimed Expert Insight: Turkish hematology centers see higher volumes of Fanconi Anemia than many European facilities. This stems from local genetic prevalence reaching 78% in certain patient groups. Dr. Zafer Gulbas alone has over 260 publications and 5,000 citations on blood disorders. This volume creates a concentrated expertise in managing the unique toxicity risks of Fanconi Anemia.
Patient Consensus: Patients emphasize finding a center that coordinates with medical genetics for family screening. They note that successful treatment requires a team familiar with specific Fanconi Anemia transplant preparation protocols.
Post-transplant follow-up for international Fanconi Anemia patients in Turkey requires intensive monitoring of donor engraftment and graft-versus-host disease (GVHD). Care lasts for several years and involves frequent bloodwork and immunosuppression management. Turkey's leading hematology centers maintain long-term coordination with home-country doctors to ensure patient safety.
Bookimed Expert Insight: Turkish hematology centers often require international patients to stay nearby for 3–4 months post-discharge. Dr. Zafer Gulbas at Anadolu Medical Center has performed over 3,300 procedures, emphasizing why experienced teams prioritize this period. This extended stay allows for rapid adjustments that standard local clinics might miss.
Patient Consensus: Patients note that recovery is a slow rebuild rather than a quick return to normal life. Coordination between the Turkish center and local doctors is the most critical factor for long-term health.